Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI –TOF Mass Spectrometry Profiling

The diagnostic of Amyotrophic lateral sclerosis (ALS) remains based on clinical and neurophysiological observations. The actual delay between the onset of the symptoms and diagnosis is about 1 year, preventing early inclusion of patients into clinical trials and early care of the disease. Therefore,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Conraux, Laurence, Pech, Catherine, Guerraoui, Halim, Loyaux, Denis, Ferrara, Pascual, Guillemot, Jean-Claude, Meininger, Vincent, Pradat, Pierre-François, Salachas, François, Bruneteau, Gaëlle, Le Forestier, Nadine, Lacomblez, Lucette
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2013
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3818176/
https://ncbi.nlm.nih.gov/pubmed/24224000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0079733
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk